Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
Author(s) |
Date | Article Title | Journal |
|---|---|---|---|
|
Zihang Zhong, Min Yang,Senmiao Ni, Lixin Cai,Jingwei Wu, Jianling Bai |
October 2022 | The heterogeneity effect of surveillance intervals on progression free survival | Journal of Applied Statistics |
|
Zhen Su, Monica M. Bertagnolli, A. Oliver Sartor, Catherine E. Symonds, Hao Zhang, Martin J. Murphy |
June 2018 | A novel, open-access data commons for improved disease management in patients (pts) with Merkel cell carcinoma (MCC) | Journal of Clinical Oncology |
|
Zhen Su, Monica M. Bertagnolli, A. Oliver Sartor, Catherine E. Symonds, Hao Zhang, Martin J. Murphy |
June 2018 | A novel, open-access data commons for improved disease management in patients (pts) with Merkel cell carcinoma (MCC) | Journal of Clinical Oncology |
|
Zahra Azizi, Chaoyi Zheng, Lucy Mosquera, Louise Pilote, Khaled El Emam, GOING-FWD Collaborators Correspondence to Dr Khaled El Emam; kelemam@ehealthinformation.ca |
March 2021 | Can synthetic data be a proxy for real clinical trial data? A validation study | BMJ Open |
|
Yu, Peter MD, ET AL |
February 2022 | Artificial Intelligence Comes of Age in the Fight Against Cancer | Oncology Times |
|
Yifei Sun, Xuming He, Jianhua Hu |
December 2022 | An omnibus test for detection of subgroup treatment effects via data partitioning | Annals of Applied Statistics |
|
Xiang Yin, Pallavi S. Mishra-Kalyan, Rajeshwari Sridhara, Mark D. Stewart,Elizabeth A. Stuart, and Ruthanna C. Davi |
January 2022 | Exploring the Potential of External Control Arms created from Patient Level Data: A case study in non-small cell lung cancer | Journal of Biopharmaceutical Statistics |
|
Wenjuan Mei, Anil Kapoor, Pierre Major, Bobby Shayegan, Damu Tang |
January 2017 | Progress towards accurate prediction of overall survival in men with metastatic castration-resistant prostate cancer | Journal of Xiangya Medicine |
|
Wei-Xiang Qi, Yi Xiang, Shengguang Zhao & Jiayi Chen |
April 2021 | Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab | Cancer Immunology, Immunotherapy |
|
Wei-xiang Qi, Shengguang Zhao, and Jiayi Chen |
October 2019 | Risk factors for developing osteonecrosis of jaw in advanced cancer patients underwent zoledronic acid treatment | Future Oncology |
|
Wei-xiang Qi, Lu Cao, Cheng Xu, Shengguang Zhao, Jiayi Chen |
February 2020 | Adjuvant regional nodal irradiation did not improve outcomes in T1-2N1 breast cancer after breast-conserving surgery: A propensity score matching analysis of BIG02/98 and BCIRG005 trials | The Breast |
|
Warit Ruanglertboon, Michael J. Sorich, Andrew Rowland, Ashley M. Hopkins |
May 2020 | Effect of early adverse events resulting in sorafenib dose adjustments on survival outcomes of advanced hepatocellular carcinoma patients | International Journal of Clinical Oncology |
|
Tomohiro Ohigashi, Kazushi Maruo, Takashi Sozu, Masahiko Gosho |
April 2022 | Using horseshoe prior for incorporating multiple historical control data in randomized controlled trials | Sage Journals |
|
Tomas G. Neilan, Mace L. Rothenberg, Laleh Amiri-Kordestani, Ryan Sullivan, Richard M. Steingart, William Gregory, Subramanian Hariharan, Terek A. Hammad, Joann Lindenfeld, Martin J. Murphy, Javid Moslehi, On Behalf of the Checkpoint Inhibitor Safety Working Group |
May 2018 | Myocarditis Associated with Immune Checkpoint Inhibitors: An Expert Consensus on Data Gaps and a Call to Action | The Oncologist |
